2383. In Vitro Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017

BACKGROUND: Pseudomonas aeruginosa (PA) is an important nosocomial pathogen. Treatment options for infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) isolates remain limited. Ceftolozane-tazobactam (C/T) and ceftazidime–avibactam (CZA) are two newer antimicrobials wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Walkty, Andrew, Adam, Heather J, Baxter, Melanie, Lagace-Wiens, Philippe, Karlowsky, James, Hoban, Daryl, Zhanel, George
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255566/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky